Literature DB >> 23645747

Characterization of low molecular weight protein tyrosine phosphatase isoforms in human breast cancer epithelial cell lines.

Irina Alho1, Luís Costa, Manuel Bicho, Constança Coelho.   

Abstract

BACKGROUND: Low molecular weight protein tyrosine phosphatase (LMW-PTP) is a polymorphic protein with two major isoforms whose role in tumorigenesis is currently controversial.
MATERIALS AND METHODS: We characterized LMW-PTP genotype, isoform expression and activity in six different human breast cancer epithelial cell lines (ZR75, MDA-MB-231, MDA-MB-231BO, MCF7, MDA-MB-231BO2, MDA-MB-435) and compared them with MCF10A, a normal breast epithelial cell line.
RESULTS: mRNA expression of the slow isoform was increased in almost all breast cancer cell lines and that of the fast isoform was reduced (p<0.05) in all breast cancer cell lines. Regarding enzymatic activity, only MCF7 had significantly lower (p<0.05) LMW-PTP activity compared to MCF10A.
CONCLUSION: Since these are novel and previously unreported findings, we propose that the differential expression of LMW-PTP fast and slow isoforms suggests their opposite roles in the tumorigenic process, with the fast isoform being anti-oncogenic and the slow isoform being oncogenic.

Entities:  

Keywords:  LMW-PTP isoforms; Protein tyrosine phosphorylation; enzymatic activity; genotype; mRNA expression

Mesh:

Substances:

Year:  2013        PMID: 23645747

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Low molecular weight protein tyrosine phosphatase as signaling hub of cancer hallmarks.

Authors:  Alessandra V S Faria; Emanuella Maria Barreto Fonseca; Helon Guimarães Cordeiro; Stefano Piatto Clerici; Carmen Veríssima Ferreira-Halder
Journal:  Cell Mol Life Sci       Date:  2020-10-14       Impact factor: 9.261

2.  Low molecular weight protein tyrosine phosphatase isoforms regulate breast cancer cells migration through a RhoA dependent mechanism.

Authors:  Irina Alho; Luis Costa; Manuel Bicho; Constança Coelho
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.